HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fumiko Chiwaki Selected Research

Pancreatic Neoplasms (Pancreatic Cancer)

1/2017A Tumor-targeting Adenovirus with High Gene-transduction Efficiency for Primary Pancreatic Cancer and Ascites Cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Fumiko Chiwaki Research Topics

Disease

12Neoplasms (Cancer)
01/2022 - 10/2012
6Stomach Neoplasms (Stomach Cancer)
01/2021 - 02/2013
3Esophageal Squamous Cell Carcinoma
01/2020 - 01/2015
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2022 - 11/2017
2Ascites
01/2021 - 01/2017
2Esophageal Neoplasms (Esophageal Cancer)
01/2020 - 02/2017
2Carcinogenesis
01/2020 - 01/2012
2Uterine Cervical Neoplasms (Cancer of the Cervix)
11/2019 - 11/2017
1Ovarian Neoplasms (Ovarian Cancer)
01/2022
1Dyslipidemias (Dyslipidemia)
01/2022
1Neoplasm Metastasis (Metastasis)
01/2021
1Pancreatic Neoplasms (Pancreatic Cancer)
01/2017
1Gallbladder Neoplasms (Gallbladder Cancer)
01/2013
1Hypersensitivity (Allergy)
10/2012
1Peritoneal Neoplasms
10/2012
1Abdominal Pain (Pain, Abdominal)
10/2012
1Cerebrovascular Disorders (Cerebrovascular Occlusion)
05/2003
1Wounds and Injuries (Trauma)
05/2003
1Heart Arrest (Cardiac Arrest)
05/2003
1Myocardial Infarction
05/2003

Drug/Important Bio-Agent (IBA)

4Biomarkers (Surrogate Marker)IBA
01/2022 - 11/2017
4Pharmaceutical PreparationsIBA
01/2022 - 01/2015
3Transforming Growth Factors (Transforming Growth Factor)IBA
01/2021 - 01/2015
2Glutathione (Reduced Glutathione)IBA
01/2020 - 11/2019
2EnzymesIBA
11/2019 - 04/2018
2AntioxidantsIBA
11/2019 - 04/2018
2AntigensIBA
01/2013 - 01/2012
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2022
1Aurora KinasesIBA
01/2022
1Messenger RNA (mRNA)IBA
01/2020
1Proteins (Proteins, Gene)FDA Link
01/2020
1MicroRNAs (MicroRNA)IBA
01/2020
1Cisplatin (Platino)FDA LinkGeneric
11/2019
1CathepsinsIBA
11/2019
1Reactive Oxygen Species (Oxygen Radicals)IBA
11/2019
1Glutamate-Cysteine LigaseIBA
11/2019
1Ligases (Synthetase)IBA
11/2019
1Aryl Hydrocarbon Receptor Nuclear TranslocatorIBA
04/2018
1Biological ProductsIBA
02/2017
1LigandsIBA
01/2017
1Epithelial Cell Adhesion MoleculeIBA
01/2017
1Thymidine KinaseIBA
05/2015
1dinophysistoxin 1IBA
05/2015
1Opioid Analgesics (Opioids)IBA
01/2015
1Docetaxel (Taxotere)FDA Link
01/2015
1CXC ChemokinesIBA
01/2015
1Narcotic Antagonists (Opioid Antagonists)IBA
01/2015
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2015
1Small Interfering RNA (siRNA)IBA
02/2013
1Complementary DNA (cDNA)IBA
01/2013
1Morphine (MS Contin)FDA LinkGeneric
10/2012
1Opioid Receptors (Opioid Receptor)IBA
10/2012
1Substance PIBA
10/2012
1Annexin A5IBA
05/2003

Therapy/Procedure

6Therapeutics
01/2021 - 01/2015
4Chemoradiotherapy
01/2020 - 01/2015
2Drug Therapy (Chemotherapy)
01/2022 - 01/2015
1Aftercare (After-Treatment)
01/2020
1Neoadjuvant Therapy
02/2017